PURE CASH PLUS
Today’s Change (Mar 18, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
A two-sleeve tactical approach: a 75% core in ultra-short bonds/cash for safety, plus a 25% signal-driven sleeve that toggles between volatility hedges and leveraged tech exposure based on momentum and volatility indicators, with daily rebalancing and broad asset overlays.
- Core cash sleeve: 75% of capital split 25%/25%/25% across PULS, BIL, and GSY to provide liquidity and downside protection.
- Tactical risk sleeve (25%): operates through two main pathways:
1) Ultimate Frontrunner: uses momentum (RSI) checks on SPY, QQQ and other proxies plus volatility signals (VIX) to decide between hedges (VXX/UVIX/VIXM) and risk-taking tranches (1.5x VIX exposure, VIX Blend) with specific weights (e.g., 45/20/35 among VXX, VIXM, UVIX in certain branches). It includes nested branches switching between “1.5x VIX Group” and “VIX Blend” depending on RSI thresholds (e.g., SPY/QQQ readings) to balance exposure to volatility vs. hedging vs. equity risk. 2) TQQQ/UVXY or Cash: uses shorter-window RSI checks to decide whether to tilt toward 3x tech (TQQQ) or hedge with UVXY, or stay in cash; also considers other asset overlays (IOO, XLP, XLF, GLD/SLV/PDBC) for diversification and to capture oversold/overbought signals. - PURE CASH PLUS: a multi-asset decision layer that aggregates signals from the prior blocks across a broad set of assets and sets final daily allocations, often still anchored by the core cash sleeve but with more frequent adjustments to capture short-term trends in tech, defensives, volatility, and commodities. - Rebalancing: intended to be daily for the cash/equivalents sleeve and as-needed or daily for tactical sleeves, depending on signal stability. - Asset focus and risk: concentrated in U.S. equities via momentum signals, coupled with volatility products (VIX-related ETFs) and limited commodity exposure for diversification. - Outcome intent: preserve capital during uncertain markets while maintaining the potential to participate in uptrends through selective moves into leveraged tech or volatility exposures. - Important caveats: use of leveraged ETFs magnifies gains and losses; complex branching can lead to whipsaws in range-bound markets; requires active monitoring and understanding of the interaction between momentum indicators and volatility hedges.
Risk-controlled, diversification-rich strategy. Out-of-sample: drawdown ~1.06% vs SPY ~5.07%; negative beta; Calmar ~8.9; Sharpe ~2.02. Lower raw return than S&P but far stronger risk-adjusted stability and capital preservation, making it a smart S&P complement.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.08 | 0.6 | 0.33 | 0.57 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 18.5% | 17.96% | -1.77% | 0.2% | 0.97 | |
| 19.54% | 18.97% | 0.19% | 0.48% | 0.96 |
Initial Investment
$10,000.00
Final Value
$11,954.15Regulatory Fees
$5.71
Total Slippage
$27.17
Invest in this strategy
OOS Start Date
Jun 24, 2025
Trading Setting
Daily
Type
Stocks
Category
Conservative core cash, tactical volatility hedges, leveraged equity exposure, dynamic momentum signals, daily rebalance
Tickers in this symphonyThis symphony trades 30 assets in total
Ticker
Type
AGG
iShares Core U.S. Aggregate Bond ETF
Stocks
BIL
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
Stocks
CURE
Direxion Daily Healthcare Bull 3X ETF
Stocks
ERX
Direxion Daily Energy Bull 2X ETF
Stocks
FNGU
MicroSectors FANG+ 3x Leveraged ETNs due February 17, 2045
Stocks
GLD
SPDR Gold Trust, SPDR Gold Shares
Stocks
GSY
Invesco Ultra Short Duration ETF
Stocks
IOO
iShares Global 100 ETF
Stocks
LABD
Direxion Daily S&P Biotech Bear 3X ETF
Stocks
LABU
Direxion Daily S&P Biotech Bull 3X ETF
Stocks